Crism Therapeutics (LSE:CRTX) Construction In Progress: £0.00 Mil (As of Dec. 2025)


LSE:CRTX Crism Therapeutics Corp LSE:CRTX
37 GF Score
Price £0.10
! 3 Warning Signs
View Full Analysis

What is Crism Therapeutics Construction In Progress?

Crism Therapeutics LSE:CRTX 37 Construction In Progress is £0.00 Mil as of Dec. 2025. GuruFocus rates LSE:CRTX with a GF Score™ of 37/100. The stock has 3 warning signs investors should review.


Crism Therapeutics Construction In Progress Historical Data

* Premium members only.

The historical data trend for Crism Therapeutics's Construction In Progress can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Crism Therapeutics Construction In Progress Chart

Crism Therapeutics Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Construction In Progress
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Crism Therapeutics Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Construction In Progress Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
LSE:CRTX
37GF Score
Crism Therapeutics Corp LSE:CRTX
Construction In Progress is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Crism Therapeutics Construction In Progress Calculation

It records the cost of construction work, which is not yet completed (typically, applied to capital budget items). A construction in progress item is not depreciated until the asset is placed in service. Normally, upon completion, a construction in progress item is reclassified, and the reclassified asset is capitalized and depreciated.

What does a Construction In Progress of £0.00 Mil mean?
Crism Therapeutics (LSE:CRTX) has a Construction In Progress of £0.00 Mil as of Dec. 2025. Construction in Progress records the amount of construction work that is not complete. View historical data on Crism Therapeutics and its competitors.
Is Crism Therapeutics' Construction In Progress too high?
Crism Therapeutics' current Construction In Progress is £0.00 Mil. Overall, Crism Therapeutics has a GF Score™ of 37/100, reflecting its overall financial health beyond just this single metric.
How does Crism Therapeutics' Construction In Progress compare to VRTX and REGN?
Crism Therapeutics' Construction In Progress of £0.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Construction In Progress for a Biotechnology company?
A good Construction In Progress depends on the Biotechnology industry context. However, Construction In Progress should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Construction In Progress mean?
A high Construction In Progress can signal that a stock is expensive relative to its fundamentals. Construction in Progress records the amount of construction work that is not complete. View historical data on Crism Therapeutics and its competitors. Crism Therapeutics's current Construction In Progress is £0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Crism Therapeutics stock overvalued right now?
Crism Therapeutics (LSE:CRTX) has a current Construction In Progress of £0.00 Mil. The current Construction In Progress is £0.00 Mil. Crism Therapeutics' overall GF Score™ is 37/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Construction In Progress calculated?
Construction In Progress is calculated from a company's financial statements. For Crism Therapeutics (LSE:CRTX), the current Construction In Progress is £0.00 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Crism Therapeutics Business Description

Address Kingston Chambers, P.O. Box 173, Tortola, Road Town, VGB
Crism Therapeutics Corp has developed a drug delivery technology to improve the clinical performance of cancer treatments for solid tumours through the local delivery of chemotherapy drugs. Its product ChemoSeed which is in its clinical trial phase, can be implanted directly into the tumour or the resection margin following the removal of a tumour. The company also provides consultancy and formulation services to its clients assisting them with pharmaceutical formulation and development.
37GF Score

Get the complete analysis for LSE:CRTX

Construction In Progress is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

£0.10
Price